Filing Details

Accession Number:
0001209191-11-050774
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-05 17:47:42
Reporting Period:
2011-10-03
Filing Date:
2011-10-05
Accepted Time:
2011-10-05 17:47:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138400 Biomimetic Therapeutics Inc. BMTI Surgical & Medical Instruments & Apparatus (3841) 621786244
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362155 Martin Earl Douglas Biomimetic Therapeutics, Inc.
389 Nichol Mill Lane
Franklin TN 37067
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-10-03 3,000 $2.92 84,144 No 4 S Direct
Common Stock Disposition 2011-10-04 3,000 $2.89 81,144 No 4 S Direct
Common Stock Disposition 2011-10-05 3,000 $2.95 78,144 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction represents the sale of 3,000 shares of common stock beneficially owned by the Reporting Person, and was made pursuant to the Reporting Person's participation in a Sales Plan to sell shares of the Issuer's common stock in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The Sales Plan was adopted in May 2011 and was designed to allow the Reporting Person to meet Federal income tax obligations due on October 15, 2011 resulting from alternative minimum tax liability based on the Reporting Person's exercise of Issuer's stock options in 2010.
  2. This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.86 and $3.05. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
  3. The balance of common stock beneficially owned includes shares acquired by the Reporting Person since the 1/21/2011 Form 4 filing, consisting of 2,109 shares purchased through the Issuer's Employee Stock Purchase Plan for 2011.
  4. This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.88 and $2.905. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
  5. This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.8602 and $3.0306. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.